Mangga, Baby Boy .

HRN: 21-83-17  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/24/2022
AMPICILLIN 1GM (VIAL)
08/24/2022
08/31/2022
IV
150mg
Q12
Potential Septic Newborn (prom X 25hours)
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: